Most malignant cells require upregulated PI3K-AKT activity and BCR-ABL1 assures its constant activation, yet in B-ALL cells it must be precisely controlled in order to avoid negative selection. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.